Siemens test system gains FDA approval

DEERFIELD -- Siemens Healthcare announced Monday its Versant 440 molecular system was approved for sale by the U.S. Food and Drug Administration for use in management of HCV-infected patients undergoing antiviral therapy. The Versant 440 system represents the next generation in automated viral load testing, providing laboratories with better samples and less hands-on time, according to the firm, based in Germany but with significant operations in Deerfield.